Streetbeat News

Products Services

EDSA

EWC

Edesa Biotech, Inc. (NASDAQ:EDSA) has secured a commitment of up to C$23 million from the Government of Canada for a pivotal Phase 3 clinical study of the company's first-in-class therapeutic candidate, EB05. The drug, which reduced mortality by 84% among critically ill patients with Acute Respiratory Distress Syndrome (ARDS) in a Phase 2 study, is designed to modulate the body's own immune response. The funding will be used towards study expenses and scale-up of commercial drug product if the development program is successful.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 4:16 pm

DVA

FMS

NVO

Fresenius Medical Care has stated that Novo Nordisk's Ozempic and other GLP-1 drugs may slow the progression of chronic kidney disease, and could also reduce the overall mortality of treated individuals.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 4:00 pm

MO

SPY

The FDA has reportedly rejected the Vuse Alto Menthol-Flavored E-cigarettes. The product is a part of the portfolio of Altria Group Inc (MO) and its rejection could impact the company's revenues.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 3:41 pm

MA

Sherri Haymond, Executive Vice President for Digital Partnerships at Mastercard, will be a featured speaker at Benzinga's Fintech Deal Day & Awards on Nov. 13 and the Future of Digital Assets conference on Nov. 14. Haymond has been instrumental in developing and commercializing solutions such as mobile payments, tokenization, open banking, and more. Last month, Xbox partnered with Barclays and Mastercard to onboard its own credit card. Haymond emphasized the rise of Banking as a Service (BaaS) and embedded finance, trends that she believes will persist in the foreseeable future.

Portfolio Pulse from Khyathi Dalal

October 12, 2023 | 3:38 pm

KIMTF

Kia (OTC:KIMTF) has unveiled three new electric models, including The Kia EV5, The Kia Concept EV3, and The Kia Concept EV4, at the brand's annual Kia EV Day in Korea. The EV5 will be produced in both China and Korea, with three variations available in the Chinese market. Kia also announced plans to develop a wide-ranging EV line-up priced from $30,000 to $80,000.

Portfolio Pulse from Nabaparna Bhattacharya

October 12, 2023 | 3:15 pm

MSFT

SPY

OpenAI, the maker of ChatGPT, is generating revenue at a pace of $1.3 billion a year, up 30% from this summer, according to CEO Sam Altman. The revenue is largely from subscriptions to its conversational chatbot, representing significant growth since the company launched a paid version of ChatGPT in February. Microsoft-backed OpenAI's revenue was just $28 million last year.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 3:13 pm

BB

EWC

BlackBerry Limited (NYSE:BB, TSX:BB) has expanded its partnership with the Government of Canada through a multi-year agreement to provide BlackBerry Cloud and BlackBerry Software to all federal departments and agencies. The agreement, signed by Shared Services Canada (SSC), will enable the daily operations of the government, reliably and securely. BlackBerry's technologies are closely aligned with the Government of Canada's priorities, including achieving net-zero emissions by 2050.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 3:01 pm

JAGX

Jaguar Health, Inc. (NASDAQ:JAGX) shares surged, reaching a high of 66 cents during premarket trading on Thursday. The company is exhibiting at the Veterinary Cancer Society Annual Conference to promote its FDA-conditionally approved drug, Canalevia-CA1. The stock is moving on extremely heavy trading volume, with over 90 million shares traded, far exceeding the 100-day average volume of just over 833 thousand shares. The shares are up 93% at 47 cents at the time of publication.

Portfolio Pulse from Erica Kollmann

October 12, 2023 | 2:59 pm

BABA

Alibaba.com and America's Beauty Show have announced a partnership to create an omnichannel platform for growth in the beauty industry. The partnership will leverage Alibaba.com's digital tools and features to offer new business opportunities and insights into beauty trends. Initiatives include launching an online pavilion featuring America's Beauty Show companies on Alibaba.com, organizing an online trade show, providing support and education to participating companies, offering global sourcing opportunities, and facilitating the participation of Alibaba.com's buyers and suppliers in the show.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 2:49 pm

JNJ

LLY

Eli Lilly plans to submit a marketing application for its Crohn's disease drug, mirikizumab, to the FDA in 2024. The drug met all major secondary endpoints in the VIVID-1 Phase 3 study, outperforming the placebo. The trial also included Johnson & Johnson's Stelara as an active control. Mirikizumab demonstrated non-inferiority versus ustekinumab, but did not achieve superiority.

Portfolio Pulse from Vandana Singh

October 12, 2023 | 2:27 pm